HONG KONG – New regulations, tighter policies and stronger enforcement in Asia Pacific have increased the risks of fraud in the life science industries and the cost of non-compliance or corruption. Employees in the region are also more conscious of their employers' ethical record. The result is a need for better and sustainable compliance programs for companies operating across Asia Pacific.